Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of a Multi-System Analysis of Opioid Receptor Binding
NCT05528848Phase 1Active, not recruiting
- Sponsor
- University of Pennsylvania
- Start
- Sep 2022
- Primary completion
- Sep 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of carfentanil in opioid use disorder (OUD) (3 arms), sponsored by University of Pennsylvania. Primary endpoints: Mu-Opioid Receptor Binding Potential Non-Displaceable measurement - [11C]carfentanil and Mu-Opioid Receptor Binding Potential Non-Displaceable measurement - naloxone and [11C]carfentanil. Started Sep 2022; status: active, not recruiting.
02
Drugs
carfentanil
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05528848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05528848.